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Sinmary The establishment of a new prostate cell line (BM1604) from a human prostatic adenocarcinoma is
reported. The line was rapidly established by culture of tissue on an extracellular matrix, previously laid down
by culture of non-related cells. The method has been shown to work well, and other prostate lines have
recently been cultured in this way. The cells have a doubling time of 28 h. DNA fingerprinting comparison of
the genome from the tumour, the germlne and the cells shows that somatic mutations have occurred in the
tumour and that clonal selection has clearly occurred in establishment of the line. Many somatic mutations are
apparent in the selected cells, which are now stable in culture. This method and the cells may be a useful
addition to the limited material available for the in vitro study of prostate cells.
Although adenocarcinoma of the prostate is a leading cause
of death due to cancer in men (Lytton, 1989; Dennis &
Mahler, 1990), very little has been reported on molecular or
cellular biological studies of these tumours and their cells.
This is in no small way because of the difficulties experienced
is establishing cell lines from individual tumours, not least of
which are the problem ofcell contamination (Nelson-Rees et
al., 1981; van Helden et al., 1988) and the presence of
prostate lines which are clonal derivatives of other lines
(Chen, 1993). Furthermore, extrapolation of studies of any
cell line established from tumour samples can be prob-
lematical owing to the clonal selection that invariably occurs.
Since these cells represent only a fraction of the whole, many
features may differ from those of other cells from the same
individual. For example, this may include a shift in gene
expression of even apparently prostate-specific molcules
(Fong et al., 1991). Changes in genotype and phenotype are
not necessarily surprising, given that somatic mutations are
increasingly being reported in malignancies.
These mutations may be detected by cytogenetic analyses,
point mutation searches, target gene structural analyses or
DNA fingerprint analysis. The last technique has been used
to show structural differences between tumour and normal
DNA from cancer patients (Armour et al., 1989; Lagoda et
al., 1989), including some prostate cancers (White et al.,
1990; Bettink et al., 1992). DNA fingerprint differences in cell
lnes established from different areas of the same tumour
have also been reported (Bettink et al., 1992). In this study
we report a new method to establish cell lines from bioptic/
surgical prostate samples using an extracellular matrix laid
down by unrelated cells and show that very substantial
somatic changes have occurred in those prostate cells clonally
selected by the culture process. Fingerprint analyses were
done using an M13 phage-derived sequence (pV47-2), which
preferentially targets sequences located on telomeres (Long-
mure et al., 1989). The results obtained show that, while
minor DNA alterations are detectable in the primary tumour
compared with the DNA from peripheral white blood cells,
substantial alterations are seen in the established cell line.
The fingerprint pattern of the established line has been stable
over many months of culture.
Materiak and n
Clinical history
A 67-year-old male (B.M.) presented with localised prostatic
adenocarcinoma. A radical prostatectomy was performed,
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and histological examination revealed a moderately well-
differentiated adenocarcinoma (Gleason 5) which was
confined to the prostate with no involvement in the apical
resection margins (Figure 1).
Tumour fragments were transferred to the laboratory for
culture in Ham's FIO medium with l0jgml-' Pipril (pip-
ricillin, Lederle) or snap frozen in liquid nitrogen. A blood
sample (10 ml) was collected on EDTA. DNA from tumour,
cells or blood was isolated according to Mathew (1984).
Cell culture
The tissue was cut into 1 mm3 pieces and dissociated in
0.125% trypsin, 0.05% EDTA, in phosphate-buffered saline
(PBS) at 4'C overnight. The tissue fragments were washed
free of trypsin and seeded into five 25-cm2 tissue culture
flasks. The explants were cultured either with serum (in
RPMI-1640 medium containing 5% fetal calf serum on stan-
dard uncoated tissue culture flasks) or without serum [in
Ham's F12 medium containing 20mM HEPES, 5g1-'
glucose, 220 mg 1-' sodium pyruvate, 500 mg l-' bovine
serum albumin fraction V, 25 mg 1' soybean trypsin
inhibitor, 25 ng ml1' epidermal growth factor, 2 1tg ml-' dex-
amethasone phosphate (Decadron) and 0.005 ng ml-' prolac-
tin]. The explants cultured without serum were plated on
ECM-coated tissue culture flasks, prepared as described
below. The flasks were placed into a humid carbon dioxide
incubator for 6 h, then closed tightly and incubated at 37TC.
The medium was changed carefully on the fifth day and
Fugwe 1 Photomicrograph of prostatic biopsy showing a
moderately well-differentiated adenocarcinoma. Scale bar:
100#m.
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thereafter twice per week. The medium added barely covered
the explants.
Preparation ofECMflasks
Extracellular matrix (ECM)-coated 25 cm2 cell culture flasks
were made according to the procedure of Golombick and
Bezwoda (1991).
Suttner cells (human ovarian carcinoma cells, a proprietary
cell line from Professor Bezwoda, Department of Medicine,
University of the Witwatersrand, South Africa) were grown
until the cultures reached complete confluency in serum-free
KSLMS medium (Kawamoto et al., 1983) containing no
bovine serum albumin (BSA), insulin or transferrin (protein-
free medium). Six to eight days later, the cells were washed
twice with water and then incubated with 0.25 N ammonium
hydroxide until the entire cell layer had dissolved, usually
within 20-30 min. The viscous solution was discarded and
the underlying extracellular matrix, which remained firmly
attached to the plastic surface, was ninsed with PBS until
pH 7.2 was reached, after which two more rinses with water
followed. The entire procedure was carried out under sterile
conditions. ECM-coated cell culture flasks were stored at 4'C
for 4-8 months. Before use the flasks were rinsed twice with
serum-free medium.
Precautions taken to avoid cell-cell contamination
The cells were grown in the laboratory which maintains the
National Cancer Association's Repository for Biological
Materials (NRBM). Stringent precautions regarding multiple
cell cultures were observed at all times to avoid any pos-
sibility of cellular cross-contamination. The BM 1604 cells
were handled by one person only, usually after hours.
Antigen marker staining
Cells were harvested, trypsinised and centrifuged to form a
small cellular pellet. This pellet was embedded in a gelatine
capsule and a cell block preparation was made. Sections of
4pm were cut and subjected to a battery of immunohis-
tochemical stains. These stains were performed utilising the
avidin-biotin complex model with diaminobenzidene as a
chromogen. Antibodies used included prostate-specific
antigen (PSA) (monoclonal, Dako 1:200; and polyclonal,
Dako 1:500), prostate-specific acid phosphatase (monoclonal,
Serotec 1:2000) and cytokeratin CAM5.2 (Becton Dickinson,
undiluted).
Supernatant fluid from the culture medium was subjected
to PSA estimation using the Tandem-R assay (Hybritec Cor-
poration). This was performed at 1, 3 and 6 months after the
establishment of the cell line.
DNAfingerprinting
DNA fingerpnnts were generated using a 32P-labelled M13-
derived multilocus probe, PV47-2. The oligonucleotide
(GTG)5 probe was a gift from Professor J.T. Epplen of the
Max Planck Institute, Martinsried, Germany.
DNA samples (10 g) were digested with restriction
endonuclease according to the manufacturer's specifications.
Enzymes used were HinfI [(GTG)5 probe] and HaeLH (PV47-
2 probe). For Hinjl, DNA samples were digested with excess
restriction enzyme as suggested by Epplen et al. (1989).
DNA fragments were electrophoresed in 0.7% agarose
horizontal slab gels. Separated fragments were transferred to
nylon membrane according to the method described by
Southern (1975). PV47-2 plasmid was labelled by random-
primed labelling according to the manufacturer's specifi-
cations and the ohigonucleotides were 3P end-labelled with
[^-3PJdATP, essentially as described by Epplen and Zischler
(1990). Filters were hybridised, washed and autoradio-
graphed (Ali et al., 1987).
The DNA fingerprints were digitised for analysis using a
Genius GT1212A tablet and custom-designed software.
Results
Isolation andgrowth ofBM 1604
After 3 weeks, a number of flasks showed cells growing out
from the adherent fragments. After 6 weeks some cells were
detached by vigorous shaking and transferred to secondary
culture. Cells grew out from fragments seeded both in serum-
containing medium and in serum-free medium on ECM-
coated plates. However, from the second passage, the cells in
serum-free medium became vacuolated and showed a slower
growth rate. Routinely therefore, all cells were grown in
RPMI-1640 medium with 5% FCS, and were subcultured by
trypsiisation.
The cell line was named BM 1604 (according to the patient's
initials and the date the specimen was received). Frozen
stocks of the cell line were prepared for liquid nitrogen
storage, and cells have been successfully thawed from these
stocks.
The cells showed a typical morphology and growth pattern
quite distinct from other cell lines. The cells grow initially in
islands which fuse when the cultures become confluent
(Figure 2). Individual cells are large and epithelial, and on
confluency they continue growing on top of the monolayer as
loosely attached rounded cells. The population doubling time
in culture is approximately 28 h.
The possibility that the BM 1604 cells had been con-
taminated with Suttner cells (which were used to lay down
the ECM) was discounted for the following reasons. Firstly,
it is not possible that any Suttner cells used in the manufac-
ture of the ECM would remain viable after the ammonium
hydroxide extraction and prolonged storage under a film of
water. Secondly, no Suttner cells were grown in the
laboratory during the period of establishment of the BM
1604 and, thirdly, the morphologies and growth patterns of
these two lines are very distinct, and would be apparent in a
mixed culture. Finally, the DNA fingerprints obtained from
the two lines are quite different (see below).
Immunohistochemical stains
The cell pellet sections demonstrated staining of cytokeratin
CAM 5.2. The stains for PSA and prostate-specific acid
phosphatase proved negative, and in the assays of PSA in the
supernatant fluid PSA values less than 1 were recorded in all
cases.
DNA analvsis
DNA, isolated from the frozen prostate, the prostate
tumour-denrved cultured cells, a blood sample from the
patient and the ovarian line, was subjected to DNA finger-
print analysis using the M13-derived multilocus probe (Vas-
Figwe 2 Phase-contrast photomicrograph of BM 1604 cells
showing both the epithelium-like monolayer and loosely attached
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sart et al., 1987). Cytogenetic (chromosome) analyses were
also done on the ovarian line and the prostate cell, and the
results (not shown) confirm that the Suttner line used to
prepare culture matrix contains two X chromosomes and is
definitely of human origin, although many chromosomal
rearrangements were detected. In contrast, the BM line had
only one X chromosome, although no Y chromosome was
detected. Many rearrangements were detected, which differed
considerably from those seen in the Suttner line.
The gross differences seen in karotype analysis were
confirmed by DNA fingerprint analysis. The results (Figure
3) show that DNA from the tumour is essenially the same as
that in the blood. A total of six locus-specific differences were
clearly discernible between the blood and tissue sample DNA
(approximately 8%), whereas a similar analysis revealed a
60% difference between the blood-derived DNA and that
from the cultured cells. A similar analysis of the cultured
prostate cells (BM 1604) and the supporting matrix cells
(Suttner) revealed a 93% difference.
Dcos
The M13-derived multilocus probe used (Vassart et al., 1987)
preferentially localises to telomeres. In spite of the relatively
localised hybridisation, such multilocus probes, by virtue of
their detection of multiple loci, can be useful for the detec-
tion of genetic alterations in tumours (Armour et al., 1989;
Lagoda et al., 1989; White et al., 1990) or clonality in cells
(Bettink et al., 1992). The former have been detected in this
way in Ca prostate samples, usually with at least one altered
band (White et al., 1990), similar to the result reported here
for the blood-tissue pair analysis in samples from patient
B.M.
In contrast, the established line (BM 1604) appears to vary
considerably from the starting material (patient B.M. DNA).
Initially, the concern was raised that cell culture contami-
nation may have occurred from the ovarian line used to
establish the ECM on which the BM cells were initially
established. However, fingerprint and chromosomal analysis
revealed that these lines are quite different. Although no Y
chromosome was detected in the prostate-derived cells, it has
been observed that the Y chromosome is sometimes lost in
malignant cells or in cells from elderly men (Pierre & Hoag-
land, 1972). Apart from this, no ovarian cells could survive
the treatment used to remove them from the dish prior to
seeding the prostate material.
Furthermore, DNA was extracted from the established
prostate line BM 1604 after 20 passages in culture, none of
which depended on ovarian line matrix, this being used in the
initial stages of culture only.
Since we were aware that cross-contamination of cell lines
can occur, precautions were taken to ensure that this did not
happen. Consequently, the prostate tumour-derived samples
and cells were handled by only one person (E.B.), usually
after hours. In addition, the prostate cells showed a very
typical morphology and growth pattern which was quite
distinct from any others in the same facilty. We are therefore
confident that the line established is derived from the pros-
tate sample.
The remarkable differences in genome structure between
the 'germ-line' DNA and that from the cell line established
from the tumour is supported by results reported elsewhere
(Bettink et al., 1992), which showed considerable differences
in the genome from different parts of the same tumour. The
observation that there are substantial differences between the
orignal genome and the genome of the cells is strongly
suggestive of clonal selection. It is therefore not necessarily
surprising that few differences were seen in our case in
tumour DNA compared with blood-derived DNA, whereas
the cell line was markedly different. The surgically removed
sample must clearly have a wide variety of (clonal) cells and
presumably many normal cells. The genotype of the cell(s)
which gave rise to the line would therefore be masked by the
signals derived from the (average) pattern of the
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Fugwe 3 a, DNA fingerprint analysis ofdifferent human cell line
and tissue samples. DNA samples were digested with HaeIII
restricon enzyme and the DNA probed with PV47-2. Lane 1,
DNA from a blood sample from patient B.M.; lane 2, DNA from
a prostatic cancer tissue sample from patient B.M.; lane 3, DNA
from a prostatic caner cell line (BM 1604) established from
patient B.M.; lane 4, DNA from an ovarian cell line (Suttner) on
which BM 1604 was established. ST, DNA moecular marker. b,
Digitised analysis of results shown in a. The autoradiograph
shown in a was digitised using a Genius GT-1212A digitising
tablet. Processing was done on a computer using specially
designed software. Lanes 1-4 and ST correspond to lanes 1-4
and ST in a.
heterogeneous tissue sample. Furthermore, quite obviously, it
is not possible to fingerprint the precise section of the tumour
that is used to establish a line.
We have previously shown and observed that a variety of
cells grown in culture appear to remain genotypically198 P.D. vAN HELDEN et al.
relatively stable (van Helden & Wiid, 1987; van Helden et al.,
1988, and unpublished observations). This was also observed
in fingerprints obtained from this line over a period of 6
months in continuous culture.
The BM 1604 cell line has an epithelial morphology, with
loosely attached cells becoming more abundant with
confluency. This appears to be characteristic of prostate cell
lines (Kaighn et al., 1979). The cells demonstrate staining of
cytokeratins, similar to that in PPC-1 cells (Brothman et al.,
1989), and have no or low amounts ofdetectable PSA, as has
been reported in PC-3 and DU-145 prostate cell lines, unlike
the LNCaP cell line (Skowronski et al., 1993). The number of
prostate cell lines available for study has become even more
limited since PPC-1 was recently reported to be a clonal
derivative of PC-3 (Chen, 1993).
We conclude that BM 1604 is a new, unique prostate-
derived cell line established using a new method, which may
join the ranks of the few prostate lines available for
molecular and cellular analyses.
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